Search Results

(-)-Sotalol 1 mg  | Purity Not Available

TargetMol

(-)-Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also shows Class III antiarrhythmic properties.

More Information Supplier Page

(-)-Sotalol 5 mg  | Purity Not Available

TargetMol

(-)-Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also shows Class III antiarrhythmic properties.

More Information Supplier Page

(-)-Sotalol 100 mg  | Purity Not Available

TargetMol

(-)-Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also shows Class III antiarrhythmic properties.

More Information Supplier Page

(-)-Sparteine 1 mL  | Purity Not Available

TargetMol

Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.

More Information Supplier Page

(-)-Sparteine 5 mg  | Purity Not Available

TargetMol

Sparteine is a class 1a antiarrhythmic agent, a sodium channel blocker. The deficient debrisoquine hydroxylation of Sparteine is due to the absence of P-450IID1 protein in the livers of poor metabolizers.

More Information Supplier Page

(-)-Sparteine Sulfate 1mg  | Purity Not Available

Selleck Chemicals

Sparteine Sulfate, a quinolizidine alkaloid, is the sulfate form of sparteini, which is a sodium channel blocker used as an oxytocic and an anti-arrhythmia agent.

More Information Supplier Page